Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Willis Towers Watson logoWillis Towers Watson WTW

The company said it held its annual general meeting of shareholders on May 22, 2024, and that 91,841,782 of the 102,257,774 ordinary shares entitled to vote as of the record date, March 25, 2024 (approximately 89.81%), were present or represented, which constituted a quorum. It said shareholders approved all of the proposals on the meeting agenda.

8-KSubmission of Matters to a Vote of Security HoldersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said it held its annual general meeting of shareholders on May 22, 2024, and that 91,841,782 of the 102,257,774 ordinary shares entitled to vote as of the record date, March 25, 2024 (approximately 89.81%), were present or represented, which constituted a quorum. It said shareholders approved all of the proposals on the meeting agenda.

  2. The company said all of the director nominees listed in the table were elected. Votes against were 4,062,088 for Paul Thomas and 3,910,459 for Carl Hess, and broker non-votes were 4,053,046 for each nominee.

  3. The company said the proposal to select auditors, including Deloitte & Touche LLP, received 91,717,077 votes for, 64,427 against and 60,278 abstentions. The advisory, non-binding vote on executive compensation received 78,725,921 votes for and 8,959,473 against.

  4. The company said shareholders approved the renewal of the directors' authority to issue shares under Irish law, up to approximately 20% of issued ordinary share capital, with 90,769,425 votes for and 996,157 against. The renewal of the authority to opt out of pre-emption rights, up to approximately 10%, received 90,578,724 votes for and 1,183,038 against.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

2024 Annual General Meeting Held and Quorum Met

The company said it held its annual general meeting of shareholders on May 22, 2024, and that 91,841,782 of the 102,257,774 ordinary shares entitled to vote as of the record date, March 25, 2024 (approximately 89.81%), were present or represented, which constituted a quorum. It said shareholders approved all of the proposals on the meeting agenda.

Source · Based on the filing body and exhibits

Director Nominees Elected and Votes Against by Nominee

The company said all of the director nominees listed in the table were elected. Votes against were 4,062,088 for Paul Thomas and 3,910,459 for Carl Hess, and broker non-votes were 4,053,046 for each nominee.

Source · Based on the filing body and exhibits

Auditor Selection Approved and Advisory Compensation Vote

The company said the proposal to select auditors, including Deloitte & Touche LLP, received 91,717,077 votes for, 64,427 against and 60,278 abstentions. The advisory, non-binding vote on executive compensation received 78,725,921 votes for and 8,959,473 against.

Source · Based on the filing body and exhibits

Renewal of Share Issuance and Pre-emption Rights Authority

The company said shareholders approved the renewal of the directors' authority to issue shares under Irish law, up to approximately 20% of issued ordinary share capital, with 90,769,425 votes for and 996,157 against. The renewal of the authority to opt out of pre-emption rights, up to approximately 10%, received 90,578,724 votes for and 1,183,038 against.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.